Trying to figure out whether Agios Pharmaceuticals deserves a spot in your portfolio? You're definitely not alone. The stock has caught the eye of investors recently, and for good reason. Over the ...

NORTH CHICAGO, Ill., Oct. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib ...

Australia is among many countries working to protect and restore nature at scale. But long-awaited environmental law reforms ...

Analysis of more than 30,000 entrepreneurial loan requests on a peer-to-peer lending platform shows that borrowers who ...

So, I think more to come on how first line selection might evolve in the next few years depending on results from other ...

Shell (LSE:SHEL) shares have edged slightly higher in recent trading, capturing investor attention as the broader energy sector contends with shifting global demand. The move offers a fresh angle for ...

Try an experiment. Next time you are in a room with someone, ask them to name everything in the room. Only certain kinds of people will say “air” or “light.” For most people, those are just givens, ...

TORONTO — Drake Powell’s usage rate in college — or lack of usage — was a red flag for some coming into the draft. But not for Jordi Fernández. The first-round pick is clearly raw, but after Powell ...